LeonaBio, Inc. Derivative, Gain (Loss) on Derivative, Net
LeonaBio, Inc. (LONA) reported Derivative, Gain (Loss) on Derivative, Net of -$132.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2021-05-13
- LeonaBio, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- LeonaBio, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2020-03-31 was -$445.00K.
- LeonaBio, Inc. derivative, gain (loss) on derivative, net for the quarter ending 2019-12-31 was $13.00K.
- LeonaBio, Inc. derivative, gain (loss) on derivative, net for fiscal 2020 was -$132.00K.
- LeonaBio, Inc. derivative, gain (loss) on derivative, net for fiscal 2019 was -$71.00K.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$132.00K 10-K · filed 2021-03-25 | ||
| 2020-09-30 | -$132.00K 10-Q · filed 2020-11-12 | |||
| 2020-03-31 | -$445.00K 10-Q · filed 2021-05-13 | -$432.00K derived: sum of 2 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$71.00K 10-K · filed 2021-03-25 | ||
| 2019-09-30 | -$84.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |